02 December 2025 | News
Image Courtesy: Public Domain
Ronovo Surgical, a global innovator in next-generation surgical robotics, announces today the appointment of Dr. Eduardo Parra-Davila and Jeroen M.M. van Heesewijk as Non-Executive Directors to its Board of Directors.
Dr. Parra-Davila is one of the world’s leading general surgeons with over 25 years of experience and over 5,000 cases of robotic surgery. He currently serves as Chief of General Surgery and Director of Minimally Invasive Colorectal Surgery and Hernia/Abdominal Wall Reconstruction at Good Samaritan Medical Center in West Palm Beach (Florida). As a founding member of the Society of Robotic Surgery (SRS) and the Clinical Robotic Surgery Association (CRSA), Dr. Parra-Davila has trained thousands of surgeons globally in minimally invasive and robotic surgery. He is also a contributing member of American College of Surgeons (ACS), Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), American Hernia Society (AHS) and American Society of Colon and Rectal Surgeons (ASCRS).
Mr. van Heesewijk is a seasoned executive with over 30 years of management experience in the medical devices industry, including professional leadership roles for 7 years in Europe and 15 years in China. He most recently served as SVP of Asia Pacific and Global Distribution at Intuitive. Previously, he served in numerous senior executive roles within Philips, including VP of Strategic Business Development at Philips Medical Systems Asia Pacific, President of Philips Medical Systems Greater China, as well as GM of Philips Balkan, Philips Romania Srl. and Philips Bulgaria Ltd. With an academic background in international law and international relations, Mr. van Heesewijk holds a profound understanding of corporate governance structures.
Dr. John Ma, Founder, Chairman, and CEO of Ronovo Surgical, commented:
“We are delighted to welcome Dr. Parra-Davila and Mr. van Heesewijk to our Board. Their extensive experience and insights will be invaluable to Ronovo as we execute our long-term strategy. These appointments reflect our commitment to strengthening corporate governance, accelerating international growth, and creating long-term value for stakeholders.”